SCHEMBL2490777

SCHEMBL2490777

COc1c(N(C)CCO)ccc(-c2ccccc2)c1-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 6/20 0.42
PDE4A P27815 5/20 0.42
PDE4C Q08493 5/20 0.42
PDE4D Q08499 5/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
USP2 O75604 3/20 0.42
CHEK1 O14757 1/20 0.38
ALDH1A1 P00352 4/20 0.36
GAA P10253 3/20 0.36
MAPT P10636 2/20 0.36
CASP1 P29466 2/20 0.36
CASP7 P55210 2/20 0.36
HBB P68871 2/20 0.36
HSD17B10 Q99714 2/20 0.36
CRHBP P24387 1/20 0.36
BRCA1 P38398 1/20 0.36
CRHR2 Q13324 1/20 0.36
PDCD1 Q15116 1/20 0.36
CD274 Q9NZQ7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2492863 0.92 PDE4B (0.40) PDE4BPDE4APDE4CPDE4DMEN1
SCHEMBL2495688 0.81 ALDH1A1 (0.41) MEN1KMT2AUSP2CHEK1ALDH1A1
SCHEMBL2492243 0.79 CHEK1 (0.40) MEN1KMT2AUSP2CHEK1ALDH1A1
SCHEMBL2492135 0.78 MEN1 (0.43) PDE4BPDE4APDE4CPDE4DMEN1
SCHEMBL2495630 0.72 PDCD1 (0.35) MEN1KMT2AUSP2CHEK1ALDH1A1
SCHEMBL2494971 0.71 MEN1 (0.50) MEN1KMT2AUSP2ALDH1A1
SCHEMBL2491890 0.71 MEN1 (0.33) MEN1KMT2AUSP2CHEK1ALDH1A1
SCHEMBL3643547 0.70 NPC1 (0.54) PDE4BPDE4APDE4CPDE4DMEN1
SCHEMBL4480101 0.70 PDE4B (0.49) PDE4BPDE4APDE4CPDE4DALDH1A1
SCHEMBL2494551 0.69 PDE4B (0.42) PDE4BPDE4APDE4CPDE4DMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH PDE4B 3369/4885PDE4A 3692/4885PDE4C 3970/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 PDE4B 3383/4885PDE4A 3742/4885PDE4C 4030/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R PDE4B 3329/4885PDE4A 3692/4885PDE4C 4023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.